Spectral AI, Inc. MDAI
Medical/Dental Instruments · IPO 2021 · data as of November 13, 2026
Spectral AI, Inc. (MDAI) is a healthcare company listed in the US with a market value of about $42M. In the twelve months to June 30, 2026 it had revenue of $15M and net income of -$10M, a net margin of -65.5%.
Its overall Stock Analiz score is 0.6 out of 5 (weak). The strongest part is future growth (1/5); the weakest is value (0/5).
Key numbers: a 5-year average ROIC of -57%.
About Spectral AI
Spectral AI is listed in the US and classified in medical/dental instruments, IPO year 2021. Revenue went from $25M in 2022 to $20M in 2025, a decline of about 8.2% a year. It was profitable in 0 of the last 5 years in our data. Its share count rose by 102% over three years (dilution for shareholders).
Score: 0.6 / 5
Checks passed
- Profit margin improving
- ROE above 15%
- More cash than debt, or low debt to equity
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- 3-year free cash flow growth above 10% a year
Valuation
Growth and quality
Financials, last 5 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue | $15M | $20M | $30M | $18M | $25M | — |
| Net income | -$10M | -$8M | -$15M | -$21M | -$3M | -$2M |
| Free cash flow | -$13M | -$10M | -$9M | -$13M | -$1M | — |
| EPS (diluted) | $-0.32 | $-0.29 | $-0.85 | $-1.48 | $-0.22 | — |
| Net margin | -65.5% | -38.5% | -51.2% | -115.5% | -11.5% | — |
| ROIC | — | -130.1% | — | — | -15.8% | -24.9% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
Frequently asked questions
Does Spectral AI pay a dividend?
Not currently.
Is Spectral AI a good stock to buy?
We do not give buy or sell advice. Spectral AI scores 0.6 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.